SGK1-dependent upregulation of connective tissue growth factor by angiotensin II

Azeemudeen Hussain1, Amanda W Wyatt, Kan Wang

  • 1Department of Physiology, University of Tübingen,Tübingen, Germany.

Insights

Angiotensin II stimulates serum- and glucocorticoid-inducible kinase (SGK1) expression, which is essential for angiotensin II-induced connective tissue growth factor (CTGF) production, suggesting SGK1

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Physiology

Background:

  • Angiotensin II is known to induce fibrosis, a process involving connective tissue growth factor (CTGF).
  • The precise signaling pathways connecting angiotensin II to CTGF production remain unclear.
  • Serum- and glucocorticoid-inducible kinase 1 (SGK1) is highly expressed in fibrotic tissues.

Purpose of the Study:

  • To investigate if angiotensin II transcriptionally regulates SGK1.
  • To determine if SGK1 plays a role in the angiotensin II-mediated regulation of CTGF expression.

Main Methods:

  • Experiments were conducted using human kidney fibroblasts and mouse lung fibroblasts.
  • Fibroblasts were derived from gene-targeted mice lacking SGK1 (sgk1-/-) and their wild-type littermates (sgk1+/+).
  • Measurements included SGK1 and CTGF protein and transcript levels following angiotensin II treatment.

Main Results:

  • Angiotensin II increased both SGK1 and CTGF protein expression in human renal fibroblasts within 4 hours.
  • In wild-type mouse fibroblasts, angiotensin II significantly upregulated SGK1 transcript levels after 4 hours.
  • Angiotensin II stimulated CTGF expression in wild-type fibroblasts, but this effect was significantly reduced in SGK1-deficient fibroblasts.

Conclusions:

  • Angiotensin II stimulates SGK1 expression.
  • SGK1 is required for angiotensin II to stimulate CTGF expression.
  • SGK1 likely contributes to the profibrotic actions of angiotensin II.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...